Aluna Raises $15.3M for Lung Health Management Platform

Aluna, the lung health management platform, has announced a partnership with ModuleMD, a practice management and EHR SaaS solution designer company, to improve patient and provider access to the latest technology in lung health. 

Patients with asthma and cystic fibrosis will now be able to seamlessly share their daily fluctuations in lung health with their doctor, enabling better outcomes and fewer attacks through earlier and more frequent interventions.

This collaboration will facilitate seamless sharing between providers, payers, and patients throughout the Aluna RPM care management platform with all the details integrated into the providers' workflow in ModuleMD.

Earlier in the week, Aluna also announced that it had completed a $15.3 million Series B round of financing to continue growing its solution among doctors and patients managing asthma, cystic fibrosis and COPD. 

Aluna’s AI-enabled respiratory management platform allows patients to transmit data to their doctor by blowing into their innovative spirometer daily. The patient-facing app allows patients to collect symptoms, medication, activity, and environmental factors easily. Their proprietary ML algorithms help medical teams identify respiratory problems and take corrective action to keep their health under control.

Aluna’s FDA-cleared spirometer device and easy-to-use app encourage patients to easily share their lung health with their doctor while on the go. This allows allergists, pulmonologists and other providers to offer care early and avoid costly and frightening hospital visits for the patient. Aluna is eligible for insurance coverage under Remote Patient Monitoring.

The Series B funding comes on the heels of a year of rapid growth, with Aluna adding thousands of new patients to its platform for a year-over-year growth rate of 10x. The company plans to invest both on the product and commercial side to produce more spirometers, make its offering more robust and reach new patients.

Join the HealthXL Meeting on ‘Digital Biomarkers for Mental Health Evaluation and Management’ on 16th February. Click here to Request to Join. 

Click here to read the original news story.